Diabetes News
-
Prediabetes May Harm Your Brain
New research suggests prediabetes may pose a threat to brain health.
-
Go Low-Carb for Type 2 Diabetes Remission?
Tough limits on carbohydrates in your meals can help get type 2 diabetes under control -- but the benefits typically wane over time, a new research review shows.
-
Coffee, Green Tea May Help Against Type 2 Diabetes
The study found that having four or more cups of green tea along with two cups of coffee daily was linked to a 63% lower risk of death during the average five-year follow-up.
-
Cells That Drive Diabetes Seen in Healthy People
Scientists knew that dangerous T-cells lived in the pancreases of people with type 1 diabetes, but a new study shows they also take up residence in the pancreases of healthy individuals.
-
Recall Widens for Diabetes Drug Metformin
The FDA has been investigating the presence of nitrosamines, known to be a possible carcinogen, in the popular diabetes medications since December, when it was first discovered in drugs in other countries. The agency said this month they still do not know the source of nitrosamines in the medications.
-
Trial Holds Promise for Weekly Insulin for Type 2
Now, new research offers some hope for those insulin avoiders -- a once-a-week insulin injection may someday replace daily shots.
-
Drinking Raises Blood Pressure Risk With Diabetes
It's probably a good idea to skip that second glass of wine if you have diabetes, because new research suggests that having more than one drink daily raises your risk of high blood pressure.
-
Common Diabetes Meds Tied to Complication Risk
People taking a class of diabetes medications called SGLT2s have up to three times the risk for a serious complication called diabetic ketoacidosis (DKA) compared to people taking another drug, new research reveals.
-
Type 1 Diabetes Costs $2,500 a Year With Insurance
Out-of-pocket costs for Americans with type 1 diabetes average $2,500 a year, a new study says.
-
Metformin Recalled for Possible Cancerous Chemical
The recall for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex comes after one lot tested by the U.S. Food and Drug Administration had higher NDMA levels than allowed by the FDA.
-
Medicare Recipients May Get Insulin at $35 Per Month
Beginning next year, people on some Medicare Part D or Medicare Advantage Plans who need insulin will be able to access the lifesaving medication for just $35 a month, according to a new plan announced by the White House.
-
Price Hike Lead Patients to Craigslist for Insulin
A new study found that hundreds of ads were placed on Craigslist for insulin and asthma inhalers during a 12-day period in June 2019.
-
Diabetes Among U.S. Young, Especially Asians, Continues to Climb
They found rates were generally higher in blacks and Hispanics than in whites. Surprisingly, the rate in Asian/Pacific Islanders rose faster than in all other racial ethnic groups.
-
Recall: Faulty Insulin Pump Blamed for One Death
Medtronic says the malfunctioning pumps are missing or have a broken retainer ring, which helps lock an insulin cartridge in place. Without this ring, or if it’s broken, the pump may deliver too little or too much insuli
-
FDA Not Recommending Recalls of Diabetes Drug
The FDA began testing samples of metformin for the carcinogen NDMA at the end of last year. Contamination with this substance has led to recalls of blood pressure and heartburn medications within the past 2 years.
-
Negotiating Insulin Costs Could Save U.S. Billions
The researchers said that if Medicare were allowed to negotiate drug prices like the U.S. Department of Veterans Affairs (VA) can, Medicare could save about $4.4 billion just on insulin.
-
Popular Diabetes Drug May Contain a Carcinogen
More than 30 million people in the U.S. have diabetes, and 90 to 95% are type 2, the CDC says, and metformin is the fourth-most prescribed drug in the United States.
-
Diabetes Tougher on Women's Hearts
Heart disease occurs an average of 15 years earlier in people with diabetes, and is their main cause of illness and death. In women, the connection between diabetes and heart disease is particularly strong.
-
Diabetes Technology Often Priced Out of Reach
New technologies designed to improve blood sugar management often cost too much for people to afford.
-
FDA OKs Diabetes Drug for Type 2 Heart Failure Risk
The FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it.
-
Next-Gen Artificial Pancreas Boosts Blood Sugar Control
The device combines an insulin pump, a continuous glucose monitor and a computer algorithm.
-
You've Lost the Weight -- Now Keep It Off to Keep Diabetes at Bay
After losing weight with a yearlong intervention, blood sugar and blood pressure levels go down and cholesterol results improve. People who kept at least 75% of that weight off for another three years retained or had even greater health benefits, the study reported.
-
Could a Pill Replace Insulin Shots?
This experimental pill can withstand the trip through the gastrointestinal tract, scientists report. When it gets to the small intestine, it breaks down into dissolving microneedles that attach to the intestinal wall and release the drug into the bloodstream.
-
Just a Little Weight Loss Can Put Diabetes Into Remission
Researchers found that losing just 10% of your body weight during the first five years you have the disease can lead to remission of type 2 diabetes.
-
Older Diabetics May Be Getting Too Much Insulin
Older, sicker patients tend to be the ones most likely to still be using insulin to manage their blood sugar, despite guidelines that suggest it's often safer to lower diabetes treatment intensity with age.
Pagination